HERON THERAPEUTICS, INC. /DE/ Annual Costs and Expenses in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Heron Therapeutics, Inc. /De/ quarterly/annual Costs and Expenses history and growth rate from 2017 to 2023.
  • Heron Therapeutics, Inc. /De/ Costs and Expenses for the quarter ending June 30, 2024 was $32M, a 40.8% decline year-over-year.
  • Heron Therapeutics, Inc. /De/ Costs and Expenses for the twelve months ending June 30, 2024 was $136M, a 17.1% decline year-over-year.
  • Heron Therapeutics, Inc. /De/ annual Costs and Expenses for 2023 was $173M, a 24.1% decline from 2022.
  • Heron Therapeutics, Inc. /De/ annual Costs and Expenses for 2022 was $227M, a 25.2% decline from 2021.
  • Heron Therapeutics, Inc. /De/ annual Costs and Expenses for 2021 was $304M, a 3.99% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $173M -$54.9M -24.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 $227M -$76.7M -25.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 $304M -$12.6M -3.99% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $317M -$39.9M -11.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 $357M +$95.3M +36.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $261M +$36.1M +16% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $225M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.